New oral arthritis drug tofacitinib 'as effective as TNF inhibitors'

Rheumatoid arthritis (RA) patients who fail to respond to traditional disease-modifying drugs could soon benefit from an alternative to injectable biologic agents.

by
Other JAK inhibitors are also in development for rheumatoid arthritis | SCIENCE PHOTO LIBRARY
Other JAK inhibitors are also in development for rheumatoid arthritis | SCIENCE PHOTO LIBRARY

To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content.

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package